**Core Concept**
Von Hippel-Lindau (VHL) disease is a genetic disorder characterized by the development of benign and malignant tumors in multiple organ systems, primarily due to mutations in the VHL gene. This gene acts as a tumor suppressor, playing a crucial role in the regulation of cellular growth and proliferation.

**Why the Correct Answer is Right**
The correct answer will be an option that is NOT associated with VHL disease. The VHL gene product, pVHL, regulates the stability and function of hypoxia-inducible factor-alpha (HIF-alpha), a transcription factor involved in angiogenesis and energy metabolism. Mutations in the VHL gene lead to the accumulation of HIF-alpha, resulting in increased expression of genes involved in angiogenesis, cell proliferation, and survival.

**Why Each Wrong Option is Incorrect**
**Option A:** Hemangioblastomas are a type of benign tumor that are commonly associated with VHL disease. They can occur in the central nervous system, retina, and other organs.
**Option B:** Renal cell carcinoma is a type of malignant tumor that is also associated with VHL disease. Individuals with VHL mutations have an increased risk of developing renal cell carcinoma.
**Option C:** Pheochromocytoma is a type of adrenal gland tumor that is associated with VHL disease. These tumors can produce excess catecholamines, leading to hypertension and other symptoms.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that VHL disease is an autosomal dominant disorder, meaning that a single copy of the mutated gene is sufficient to cause the condition. This has significant implications for genetic counseling and screening.

**Correct Answer: D.**